ACA Has Increased Rx Drug Use, Cut Out-of-Pocket Spending

This article originally appeared here.
Share this content:
ACA Has Increased Rx Drug Use, Cut Out-of-Pocket Spending
ACA Has Increased Rx Drug Use, Cut Out-of-Pocket Spending

MONDAY, Aug. 22, 2016 (HealthDay News) -- The Affordable Care Act (ACA) has increased prescription use and reduced out-of-pocket spending, according to a report published online Aug. 17 in Health Affairs.

Andrew W. Mulcahy, Ph.D., from the RAND Corporation in Arlington, Va., and colleagues examined how ACA-linked gains in health insurance coverage have affected populations at risk for high health spending. Using prescription transaction data for a panel of 6.7 million prescription drug users, the authors compared changes in coverage, prescription fills, plan spending, and out-of-pocket spending before and after implementation of the ACA's coverage expansions.

The researchers found that, compared with 2013, there was a 30 percent reduction in the proportion of this population uninsured in 2014. Compared with 2013, on average, in 2014, uninsured people who gained private coverage filled 28 percent more prescriptions and had 29 percent less out-of-pocket spending per prescription. Larger increases in fill rates and reductions in out-of-pocket spending per prescription were seen for those who gained Medicaid coverage (79 and 58 percent, respectively). Larger decreases in out-of-pocket spending were seen for people who gained coverage and had at least one of the chronic conditions listed in the report versus those who did not have at least one condition.

"By reducing financial barriers to care, the ACA has increased treatment rates while reducing out-of-pocket spending, particularly for people with chronic conditions," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Extended-Release Naltrexone Promising for Opioid Dependence

Extended-Release Naltrexone Promising for Opioid Dependence

Lower use of heroin, other illicit opioids with extended-release naltrexone in superiority analysis

New Expert Consensus Pathway for Mitral Regurgitation

New Expert Consensus Pathway for Mitral Regurgitation

Etiology, mechanism, severity, indications for treatment should be assessed after MR is identified

Many Dermatology Guideline Authors Get Industry Payments

Many Dermatology Guideline Authors Get Industry Payments

22 of 40 guideline authors receiving payments did not accurately disclose industry relationships

is free, fast, and customized just for you!

Already a member?

Sign In Now »